Alitretinoin (Panretin) gel 0.1%.
This review focuses on the use of alitretinoin (Panretin) gel 0.1% therapy as a new topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.
Rhoads
J
J
Louisiana State University Health Sciences Center School of Nursing, USA.
D000279:Administration, Cutaneous; D000077556:Alitretinoin; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005782:Gels; D006801:Humans; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000451:nursing*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000451:nursing*; D014212:Tretinoin / Q000008:administration & dosage / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D005782:Gels; D000077556:Alitretinoin; D014212:Tretinoin